Jazz Pharmaceuticals saw the highest growth of 0.82% in patent filings and 1.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.82% and grants by 1.99%. GlobalData’s DataBook provides a comprehensive analysis of Jazz Pharmaceuticals‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Jazz Pharmaceuticals has been focused on protecting inventions in United States(US) with 11 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 29% filings and 15% grants. The United States(US), European Patent Office(EPO), Japan(JP), and Israel(IL) patent Office are among the top ten patent offices where Jazz Pharmaceuticals is filings its patents. Among the top granted patent authorities, Jazz Pharmaceuticals has 27% of its grants in Israel(IL), 15% in United States(US) and 12% in Australia(AU).
Roche could be the strongest competitor for Jazz Pharmaceuticals
Patents related to rare diseases and climate change lead Jazz Pharmaceuticals's portfolio
Jazz Pharmaceuticals has the highest number of patents in rare diseases followed by, climate change and addiction. For rare diseases, nearly 60% of patents were filed and 45% of patents were granted in Q2 2024.
Epilepsy related patents lead Jazz Pharmaceuticals portfolio followed by seizures, and dravet syndrome (severe myoclonic epilepsy of infancy)
Jazz Pharmaceuticals has highest number of patents in epilepsy followed by seizures, dravet syndrome (severe myoclonic epilepsy of infancy), lennox-gastaut syndrome, and acute lymphocytic leukemia (all, acute lymphoblastic leukemia). For epilepsy, nearly 3% of patents were filed and 15% of patents were granted in Q2 2024.
For comprehensive analysis of Jazz Pharmaceuticals's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
